All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRWD / CrowdStrike Holdings, Inc.
|
|
|
|
|
|
|
|
| PL / Planet Labs PBC
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARM / Arm Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
| SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NMRA / Neumora Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
| GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
| MOND / Mondee Holdings, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| GUTS / Fractyl Health, Inc.
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
| LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
| SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
| FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
| PATH / UiPath Inc.
|
|
|
|
|
|
|
|
| NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
